Clinical Trial Update: Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 trial results assess the safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis; the study has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Genentech, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2011-06-13